Holocene Advisors’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.3M Buy
550,195
+545,673
+12,067% +$35.1M 0.09% 214
2026
Q1
$255K Sell
4,522
-1,259,749
-100% -$82M ﹤0.01% 778
2025
Q4
$101M Buy
1,264,271
+1,225,351
+3,148% +$82.3M 0.21% 128
2025
Q3
$1.9M Buy
+38,920
New +$2.41M ﹤0.01% 544
2025
Q2
Sell
-33,106
Closed -$2.1M 807
2025
Q1
$2.1M Buy
+33,106
New +$2.25M 0.01% 534
2024
Q4
Sell
-67,419
Closed -$5.42M 802
2024
Q3
$5.42M Buy
+67,419
New +$5.45M 0.02% 332
2024
Q2
Sell
-8,225
Closed -$702K 759
2024
Q1
$702K Buy
+8,225
New +$645K ﹤0.01% 661
2022
Q3
Sell
-18,463
Closed -$1.2M 864
2022
Q2
$1.2M Sell
18,463
-27,144
-60% -$1.61M 0.01% 643
2022
Q1
$2.88M Sell
45,607
-24,600
-35% -$1.34M 0.02% 403
2021
Q4
$3.72M Sell
70,207
-4,646
-6% -$283K 0.02% 390
2021
Q3
$5.28M Sell
74,853
-46,404
-38% -$2.93M 0.03% 328
2021
Q2
$8.08M Sell
121,257
-194,482
-62% -$13.8M 0.05% 237
2021
Q1
$35M Sell
315,739
-12,527
-4% -$1.55M 0.22% 133
2020
Q4
$39M Sell
328,266
-101,559
-24% -$10.9M 0.25% 137
2020
Q3
$37.5M Buy
+429,825
New +$37.6M 0.29% 113
2020
Q2
Sell
-7,441
Closed -$742K 677
2020
Q1
$742K Buy
+7,441
New +$807K 0.01% 481
2019
Q2
Sell
-2,876
Closed -$252K 684
2019
Q1
$252K Buy
+2,876
New +$262K ﹤0.01% 580
2018
Q1
Sell
-8,491
Closed -$493K 617
2017
Q4
$493K Buy
+8,491
New +$447K 0.01% 418

Other funds holding HAE

Holocene Advisors's HAE Position: Q2 2026 in Review

Holocene Advisors increased its Haemonetics (HAE) stake by 12,067% in Q2 2026, buying an estimated $35.1M and bringing the position to 550,195 shares worth $41.3M. The position accounts for 0.09% of the portfolio, ranked #214.

Holocene Advisors first reported a position in HAE in Q4 2017 and has held it in 18 quarters since. The position peaked at $101M in Q4 2025. 330 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Holocene Advisors held 550,195 shares of Haemonetics worth $41.3M as of Q2 2026.
  • Holocene Advisors bought 545,673 Haemonetics shares in Q2 2026, an estimated $35.1M.
  • Haemonetics made up 0.09% of Holocene Advisors's portfolio in Q2 2026, its #214 holding.
  • Holocene Advisors first reported a position in Haemonetics in Q4 2017 and has held it in 18 quarters since.
  • Holocene Advisors's Haemonetics position peaked at $101M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.